Dun & Bradstreet Holdings, Inc.

NYSE:DNB Stock Report

Market Cap: US$5.3b

Dun & Bradstreet Holdings Valuation

Is DNB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DNB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DNB ($12.29) is trading below our estimate of fair value ($27.07)

Significantly Below Fair Value: DNB is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DNB?

Key metric: As DNB is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for DNB. This is calculated by dividing DNB's market cap by their current revenue.
What is DNB's PS Ratio?
PS Ratio2.3x
SalesUS$2.38b
Market CapUS$5.29b

Price to Sales Ratio vs Peers

How does DNB's PS Ratio compare to its peers?

The above table shows the PS ratio for DNB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.3x
EXPO Exponent
9.5x6.0%US$4.8b
AMTM Amentum Holdings
1x23.6%US$5.3b
SAIC Science Applications International
0.8x3.0%US$5.9b
FCN FTI Consulting
1.9x4.8%US$7.0b
DNB Dun & Bradstreet Holdings
2.3x4.9%US$5.3b

Price-To-Sales vs Peers: DNB is good value based on its Price-To-Sales Ratio (2.3x) compared to the peer average (3.3x).

Price to Sales Ratio vs Industry

How does DNB's PS Ratio compare vs other companies in the US Professional Services Industry?

26 CompaniesPrice / SalesEstimated GrowthMarket Cap
MAN ManpowerGroup
0.2x2.1%US$2.83b
CNXC Concentrix
0.3x3.2%US$2.42b
TIXT TELUS International (Cda)
0.4x3.1%US$961.19m
CNDT Conduent
0.2x-2.0%US$569.21m
DNB 2.3xIndustry Avg. 1.4xNo. of Companies26PS01.63.24.86.48+
26 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: DNB is expensive based on its Price-To-Sales Ratio (2.3x) compared to the US Professional Services industry average (1.4x).

Price to Sales Ratio vs Fair Ratio

What is DNB's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DNB PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2.3x
Fair PS Ratio2.9x

Price-To-Sales vs Fair Ratio: DNB is good value based on its Price-To-Sales Ratio (2.3x) compared to the estimated Fair Price-To-Sales Ratio (2.9x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DNB forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$12.29
US$14.63
+19.1%
16.3%US$19.00US$11.90n/a9
Nov ’25US$11.91
US$14.63
+22.9%
16.3%US$19.00US$11.90n/a9
Oct ’25US$11.50
US$14.07
+22.3%
17.7%US$19.00US$11.80n/a10
Sep ’25US$12.00
US$13.93
+16.1%
17.8%US$19.00US$11.00n/a11
Aug ’25US$10.29
US$14.19
+37.9%
19.5%US$19.00US$10.40n/a10
Jul ’25US$9.14
US$14.19
+55.3%
19.5%US$19.00US$10.40n/a10
Jun ’25US$9.59
US$14.19
+48.0%
19.5%US$19.00US$10.40n/a10
May ’25US$9.23
US$14.20
+53.8%
17.4%US$18.00US$11.00n/a10
Apr ’25US$9.95
US$14.30
+43.7%
17.1%US$18.00US$11.00n/a10
Mar ’25US$10.60
US$14.50
+36.8%
15.7%US$18.00US$11.00n/a12
Feb ’25US$11.79
US$14.48
+22.8%
17.5%US$18.00US$10.30n/a12
Jan ’25US$11.70
US$14.32
+22.4%
17.4%US$18.00US$10.30n/a12
Dec ’24US$10.88
US$14.25
+31.0%
18.2%US$18.00US$10.30n/a11
Nov ’24US$9.18
US$14.58
+58.9%
15.0%US$18.00US$11.00US$11.9112
Oct ’24US$9.99
US$14.92
+49.4%
15.3%US$18.00US$11.00US$11.5013
Sep ’24US$10.83
US$14.86
+37.2%
14.9%US$18.00US$11.00US$12.0014
Aug ’24US$11.64
US$14.71
+26.4%
15.2%US$18.00US$11.00US$10.2914
Jul ’24US$11.57
US$14.71
+27.2%
15.2%US$18.00US$11.00US$9.1414
Jun ’24US$9.98
US$14.71
+47.4%
15.2%US$18.00US$11.00US$9.5914
May ’24US$11.07
US$14.86
+34.2%
14.1%US$18.00US$12.00US$9.2314
Apr ’24US$11.74
US$14.86
+26.6%
14.1%US$18.00US$12.00US$9.9514
Mar ’24US$12.06
US$14.86
+23.2%
14.1%US$18.00US$12.00US$10.6014
Feb ’24US$14.96
US$15.96
+6.7%
14.9%US$21.00US$12.50US$11.7914
Jan ’24US$12.26
US$16.18
+32.0%
14.2%US$21.00US$12.50US$11.7014
Dec ’23US$13.73
US$16.18
+17.8%
14.2%US$21.00US$12.50US$10.8814
Nov ’23US$12.94
US$17.71
+36.9%
15.2%US$24.00US$14.50US$9.1814

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y